Valuation : Edwards Lifesciences Corporation

Market Cap 49.99B 42.97B 40.49B 36.9B 69B 4,755B 69.26B 479B 185B 2,424B 188B 184B 7,674B P/E 2026 *
34.3x
P/E 2027 * 26.2x
Enterprise Value 46.35B 39.85B 37.55B 34.22B 63.98B 4,410B 64.23B 444B 172B 2,248B 174B 170B 7,116B EV / Sales 2026 *
6.86x
EV / Sales 2027 * 6.03x
Free-Float
86.96%
Yield 2026 *
-
Yield 2027 * -
1 day-0.62%
1 week-5.03%
Current month-5.04%
1 month-3.95%
3 months+0.38%
6 months+5.56%
Current year+1.09%
1 week 85.73
Extreme 85.73
91.53
1 month 85.73
Extreme 85.73
93.91
Current year 74.66
Extreme 74.66
96.29
1 year 72.3
Extreme 72.3
96.29
3 years 58.93
Extreme 58.93
96.29
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 2023-05-10
Director of Finance/CFO 43 2026-05-28
Chief Tech/Sci/R&D Officer 51 2025-08-31
Director TitleAgeSince
Chairman 69 2024-05-06
Director/Board Member 62 2015-02-09
Director/Board Member 58 2023-05-10
Date Insider Type Main position Quantity % Market Cap. Importance
8/31/26 Sell

Controller/Auditor

-544 0.0001%
8/28/26 Sell

Executive/Senior Manager

-2,644 0.0005%
8/26/26 Sell

Executive/Senior Manager

-1,240 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-0.62%-5.03%+7.44%+16.35% 49.99B
+0.44%+0.86%+24.21%+16.87% 223B
-0.19%-1.01%+3.13%-17.52% 144B
+0.88%-4.34%-24.84%+18.45% 124B
-0.04%-6.49%-58.42%-16.54% 65.19B
-0.79%-1.55%-18.62%-13.39% 50.49B
-1.43%-3.45%+12.97%+26.98% 41.4B
+0.47%-0.25%+30.85%+53.59% 39.59B
-2.87%-1.03%+108.80%+29.45% 31.87B
-0.50%-4.93%-21.29%+48.67% 31.62B
Average -0.47%-2.18%+6.42%+16.29% 80.11B
Weighted average by Cap. -0.05%-1.91%+3.68%+10.35%

Financials

2026 *2027 *
Net sales 6.76B 5.81B 5.48B 4.99B 9.33B 643B 9.37B 64.74B 25.03B 328B 25.37B 24.83B 1,038B 7.43B 6.39B 6.02B 5.48B 10.25B 707B 10.29B 71.16B 27.51B 360B 27.89B 27.29B 1,141B
Net income 1.44B 1.23B 1.16B 1.06B 1.98B 137B 1.99B 13.75B 5.31B 69.58B 5.39B 5.27B 220B 1.9B 1.63B 1.54B 1.4B 2.62B 180B 2.63B 18.17B 7.02B 91.96B 7.12B 6.97B 291B
Net Debt -3.63B -3.12B -2.94B -2.68B -5.01B -345B -5.03B -34.78B -13.45B -176B -13.63B -13.34B -557B -5.19B -4.47B -4.21B -3.83B -7.17B -494B -7.2B -49.76B -19.24B -252B -19.5B -19.08B -797B
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
26-09-09 $86.18 -0.62% 2,735,535
26-09-08 $86.72 -3.54% 3,583,538
26-09-04 $89.90 +0.13% 2,635,295
26-09-03 $89.78 -1.15% 1,844,143
26-09-02 $90.82 +0.09% 2,595,780
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
86.72USD
Average target price
100.96USD
Spread / Average Target
+16.42%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!